Log in Book a Demo

US Pharma & Biotech Neuroscience - PPC Market Share Analysis May 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Neuroscience category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
vraylar.com 33.56
nurtec.com 10.89
caplyta.com 9.24
cobenfyhcp.com 5.57
fanapt.com 3.49
rexulti.com 3.34
caplytahcp.com 3.28
vraylarhcp.com 2.98
invegasustennahcp.com 2.49
cobenfy.com 2.19
others 22.97

Copyright © Adthena. All rights reserved.

In the competitive landscape of Google PPC ads, vraylar.com leads with a 33.56% click share. Nurtec.com follows at 10.89%, while ‘others’ collectively hold 22.97%, showcasing diverse advertiser presence.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date vraylar.com nurtec.com vraylarhcp.com cobenfyhcp.com fanapt.com invegasustennahcp.com ubrelvy.com caplyta.com caplytahcp.com rexulti.com
2025/05/01 21.04% 12.65% 0.44% 5.26% 0% 0.12% 16.24% 20.31% 0% 0%
2025/05/02 13.16% 10.75% 11.07% 5.2% 0% 1.75% 8.02% 10.72% 5.92% 0%
2025/05/03 0.61% 10.31% 0.15% 6.66% 1.5% 0.52% 1.55% 23.15% 12.87% 0%
2025/05/04 59.31% 4.63% 6.18% 1.68% 3.32% 1.83% 0.17% 8.75% 0% 0%
2025/05/05 26.8% 3.1% 11.3% 3.45% 0% 3.86% 2.75% 12.83% 7.19% 0.03%
2025/05/06 0.36% 7.79% 7.5% 11.27% 7.99% 4.46% 1.31% 27.06% 11.29% 0%
2025/05/07 41.5% 1.34% 6.68% 4.09% 1.43% 0.39% 0.11% 17.86% 9.9% 0%
2025/05/08 19.84% 10.33% 0.24% 5.27% 2.32% 0.03% 0.17% 20.24% 12.86% 0%
2025/05/09 44.19% 5.68% 4.94% 0.45% 0.3% 0.01% 2.41% 8.54% 4.68% 0%
2025/05/10 27.02% 6.5% 0.15% 9.29% 0.01% 0.02% 2.59% 21.01% 11.69% 0%
2025/05/11 26.03% 8.36% 0.18% 0.24% 0.01% 0.15% 0.63% 19.75% 10.99% 0.01%
2025/05/12 49.98% 4.12% 0.01% 2.04% 2.12% 1.2% 1.32% 15.17% 8.44% 0.07%
2025/05/13 0.01% 5.14% 0.01% 8.31% 7.13% 7.07% 1.01% 28.72% 7.75% 0.01%
2025/05/14 29.99% 3.29% 3.21% 11.16% 4.04% 2.13% 0.08% 14.55% 7.96% 0.18%
2025/05/15 16.27% 10.42% 6.82% 6.73% 4.54% 0.29% 1.17% 12.82% 8.95% 8.67%
2025/05/16 28.63% 4.52% 6.15% 4.9% 4.52% 5.55% 0.32% 16.38% 6.08% 0.01%
2025/05/17 0% 11.79% 0.01% 1.85% 3.15% 3.65% 4.67% 5.76% 6.04% 30.03%
2025/05/18 0.54% 17.19% 0.17% 7.45% 6.08% 3.42% 4.61% 20.45% 11.37% 0.03%
2025/05/19 33.13% 2.28% 0.12% 9.42% 3.36% 3.28% 3.39% 12.49% 9.76% 0.01%
2025/05/20 0.24% 9.77% 0.06% 2.69% 0.36% 2.75% 0.24% 27.29% 15.18% 0.01%
2025/05/21 32.77% 5.05% 4.71% 4.7% 7.61% 5.56% 0.84% 0.71% 3.44% 11.76%
2025/05/22 47.51% 9.89% 15.07% 0.05% 0% 0% 1.63% 0% 6% 0%
2025/05/23 27.64% 13.82% 0% 5.7% 6.93% 2.47% 3.82% 6.96% 3.87% 0%
2025/05/24 34.46% 8.03% 0.18% 8.43% 3.13% 0.17% 0.09% 13.59% 7.29% 0.12%
2025/05/25 60.77% 2.85% 20.38% 0.58% 0.46% 0.15% 0.06% 0% 0% 0.01%
2025/05/26 0.63% 24.34% 0.01% 3.16% 4.78% 3.79% 7.41% 0% 6.1% 0.04%
2025/05/27 0% 14.44% 0.01% 8.07% 11.55% 6.08% 0.9% 10.18% 7.78% 0.08%
2025/05/28 23.21% 9.52% 6.52% 3.32% 1.13% 1% 3.47% 12.02% 3.29% 8.21%
2025/05/29 0.32% 21.81% 6.73% 6.43% 4.25% 4.11% 3.81% 9.67% 3.1% 0.02%
2025/05/30 27.43% 13.07% 11.4% 10.6% 0.01% 3.78% 3.6% 0% 2.69% 0.02%
2025/05/31 40.87% 10.06% 6.89% 4.12% 2.82% 2.7% 2.44% 0.29% 0.14% 0.02%

Copyright © Adthena. All rights reserved.

In May 2025, Vraylar.com dominated with fluctuating spend, peaking at 60.77. Nurtec.com maintained steady activity, while Vraylarhcp.com saw sporadic spikes. Cobenfyhcp.com and Fanapt.com showed moderate engagement. Caplyta.com had consistent presence, ending with a dip.

Market Exposure

Competitor Count for US Pharma & Biotech Neuroscience

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/05/01 48
2025/05/02 50
2025/05/03 44
2025/05/04 49
2025/05/05 58
2025/05/06 54
2025/05/07 51
2025/05/08 51
2025/05/09 57
2025/05/10 53
2025/05/11 61
2025/05/12 66
2025/05/13 71
2025/05/14 63
2025/05/15 66
2025/05/16 60
2025/05/17 67
2025/05/18 60
2025/05/19 64
2025/05/20 60
2025/05/21 59
2025/05/22 57
2025/05/23 55
2025/05/24 63
2025/05/25 51
2025/05/26 51
2025/05/27 56
2025/05/28 68
2025/05/29 59
2025/05/30 58
2025/05/31 56

Copyright © Adthena. All rights reserved.

May began with 48 advertisers, fluctuating throughout the month, peaking at 71 on May 13. The month concluded with 56 advertisers, reflecting dynamic competition.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
vyepti.com 1.9%
nurtec.com 1.8%
ubrelvy.com 1.24%
cobenfy.com 1.03%
amenclinics.com 0.78%
caplytahcp.com -0.57%
upenn.edu -0.67%
rexultihcp.com -1.12%
rexulti.com -1.91%
caplyta.com -5.75%

Copyright © Adthena. All rights reserved.

Vyepti.com leads with a 1.9% click share rise, while caplyta.com drops by 5.75%.

Campaign Efficiency

US Pharma & Biotech Neuroscience Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date vraylar.com nurtec.com cobenfyhcp.com vyepti.com vraylarhcp.com ubrelvy.com fanapt.com invegasustennahcp.com caplytahcp.com caplyta.com
2025/05/01 9.04% 14.77% 10.4% 1.13% 0.39% 20.11% 0.01% 0.18% 0% 9.94%
2025/05/02 5% 8.81% 7.91% 7.42% 10% 12.93% 0% 3.67% 3.8% 3.8%
2025/05/03 0.31% 9.7% 13.08% 2.4% 0.16% 1.69% 0.96% 0.85% 10.69% 10.69%
2025/05/04 33.5% 4.57% 4.5% 0.5% 8.35% 0.29% 8.65% 4.1% 0% 6.12%
2025/05/05 12.32% 2.86% 7.25% 0.39% 12.33% 2.75% 0% 6.72% 7.67% 10.51%
2025/05/06 0.13% 5.36% 18.87% 1.38% 6.3% 1.21% 15.24% 6.21% 6.78% 9.04%
2025/05/07 22.38% 1.54% 9.01% 0.06% 11.37% 0.07% 4.09% 0.6% 14.28% 10.2%
2025/05/08 10.14% 9.44% 12.85% 0.33% 0.33% 0.11% 5.4% 0.02% 17.6% 11.41%
2025/05/09 22.54% 5.14% 1% 1.3% 11.4% 2.48% 0.49% 0.02% 4.09% 4.21%
2025/05/10 13.97% 5.07% 20.95% 0.94% 0.16% 2.04% 0.02% 0.03% 10.25% 10.24%
2025/05/11 12.49% 8.2% 0.53% 1.49% 0.29% 0.6% 0.02% 0.26% 9.17% 9.16%
2025/05/12 28.72% 4.94% 5.75% 4.03% 0.01% 2.06% 5.79% 2.81% 8.43% 8.42%
2025/05/13 0% 3.71% 14.03% 0.55% 0.01% 0.78% 10.44% 9.87% 4.93% 14.79%
2025/05/14 11.42% 2.27% 18.17% 0.63% 5.73% 0.05% 6.99% 3.04% 10.47% 10.05%
2025/05/15 6.72% 9.05% 12.12% 5.68% 6.69% 2.03% 9.46% 0.43% 6.33% 4.96%
2025/05/16 13.21% 4.22% 10.56% 2.6% 6.76% 0.42% 9.67% 10.06% 4.75% 7.11%
2025/05/17 0% 8.98% 3.13% 6.58% 0.02% 6.48% 5.28% 5.16% 3.74% 3.74%
2025/05/18 0.21% 14.43% 12.93% 7.19% 0.14% 6.45% 10.19% 4.95% 7.11% 7.11%
2025/05/19 14.14% 1.74% 17.69% 2.98% 0.11% 5.17% 6.33% 5.32% 10.87% 5.15%
2025/05/20 0.13% 9.04% 5.48% 3.68% 0.09% 0.36% 0.53% 4.68% 11.79% 11.79%
2025/05/21 13.21% 4.18% 8.87% 2.37% 4.51% 0.74% 13.05% 8.61% 6.57% 0.23%
2025/05/22 20.5% 9.48% 0.1% 8.79% 15.43% 3.09% 0.01% 0% 13.6% 0%
2025/05/23 10.4% 11.85% 9.2% 9% 0% 6.48% 11.85% 3.56% 2.51% 2.51%
2025/05/24 16.11% 7.17% 17.94% 6.41% 0.18% 0.08% 6.38% 0.17% 5.84% 6.05%
2025/05/25 37.23% 4.25% 1.42% 6.29% 29.83% 0.06% 0.97% 0.3% 0% 0%
2025/05/26 0.22% 16.11% 4.97% 9.15% 0.01% 11.16% 5.62% 4.94% 9.87% 0%
2025/05/27 0% 10.19% 11.98% 4.35% 0.01% 1.03% 17.28% 7.53% 6.58% 5.64%
2025/05/28 9.81% 8.73% 6.57% 5.09% 6.54% 6.28% 1.72% 1.57% 2.36% 5.89%
2025/05/29 0.1% 14.08% 8.44% 6.2% 4.8% 5.23% 6.16% 4.8% 4.59% 5.17%
2025/05/30 9.85% 10.55% 18.29% 5.75% 9.86% 5.74% 0.01% 7.23% 4.82% 0%
2025/05/31 16.93% 9.56% 7.18% 6.96% 6.85% 4.59% 4.55% 4.14% 0.09% 0.09%

Copyright © Adthena. All rights reserved.

In May 2025, Vraylar.com saw fluctuating ad impressions, peaking at 37.23% on May 25. Nurtec.com maintained a steady presence, while Cobenfyhcp.com had a notable spike on May 10. Vyepti.com and Ubrelvy.com showed consistent low activity. Fanapt.com and Invegasustennahcp.com had sporadic peaks. Caplyta.com ended the month with minimal impressions.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    Medication For Schizophrenia - FDA Approved SCZ Treatment

    Psychiatrists: Learn About A Prescription Approved To Treat Adults With Schizophrenia. Visit The HCP Site For Information On An FDA...

  2. 2
    Schizophrenia Treatment Option - View Dosing & Admin Guide

    HCPs - Guide Your Adult Patients' Journey With This Treatment. Find Prescribing Info Here.

  3. 3
    Migraine Treatment Tablet - Can Disintegrate In Seconds

    Learn about an Rx migraine treatment that is available as an orally disintegrating tablet. Learn about an Rx migraine treatment that...

  4. 4
    VRAYLAR® (cariprazine) - Savings Card Information https://www.vraylar.com/

    See VRAYLAR® (cariprazine) Full Prescribing Information, Including Boxed Warnings. Start the Conversation With Your Healthcare Provider About VRAYLAR®. See Site for Details.

  5. 5
    Preventive Migraine Treatment - A Different Migraine Treatment

    Start the conversation with your doctor. Ask if this treatment could be right for you. FAQs.

Copyright © Adthena. All rights reserved.

In the competitive landscape of pharmaceuticals, top-performing PPC ads reveal a focus on schizophrenia and migraine treatments. Advertisers like cobenfyhcp.com and invegasustennahcp.com emphasize FDA-approved schizophrenia solutions, targeting healthcare professionals with detailed prescribing information. Meanwhile, nurtec.com and vyepti.com highlight innovative migraine treatments, promoting unique delivery methods and encouraging patient-doctor conversations. Vraylar.com stands out with savings card offers, enhancing patient engagement.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

Related reports

US
Pharma & Biotech

US Pharmacology

US
Pharma & Biotech

US Research and Development

US
Pharma & Biotech

US Pulmonology

UK
Pharma & Biotech

UK Pharmacology